肠易激综合征女性的性功能障碍会降低其一般和特定生活质量。一项横断面研究。

Sexual dysfunction worsens both the general and specific quality of life of women with irritable bowel syndrome. A cross-sectional study.

机构信息

Gastroenterology Service, Mexico General Hospital "Dr Eduardo Liceaga", Dr. Balmis No 148, Col. Doctores. Alcaldía Cuauhtémoc, México City, 06720, Mexico.

Psychology Department, Iberoamerican University, México City, Mexico.

出版信息

BMC Womens Health. 2023 Mar 27;23(1):134. doi: 10.1186/s12905-023-02272-9.

Abstract

BACKGROUND

Irritable bowel syndrome (IBS) and sexual dysfunction (SxD) lowers quality of life (QOL) separately, but the effect of their overlap in unselected populations has not been studied.

OBJECTIVE

To evaluate the QOL of IBS women with and without SxD and compare it with controls.

METHODS

In this cross-sectional assessment, we studied 51 IBS women (Rome IV criteria) and 54 controls. SxD was determined using the female sexual function index questionnaire. QOL was evaluated by the Short Form 36 (SF-36) and IBS-QOL questionnaires.

RESULTS

SxD prevalence was similar between IBS women (39.22%) and controls (38.89%). Compared with other groups, IBS patients with SxD showed lower scores in all domains as well as in the physical, mental summaries of the SF-36 and almost all domains (except for body image, food avoidance, and social reaction compared with IBS patients without SxD) and the total score of IBS-QOL.

CONCLUSIONS

These findings show that SxD worsens both general and specific QOL of women with IBS. The consideration of SxD in patients with IBS will allow us to make a more effective diagnostic and therapeutic approach. Clinical trial registry in Mexico City General Hospital: DI/19/107/03/080.

CLINICAL TRIALS REGISTRATION

NCT04716738.

摘要

背景

肠易激综合征(IBS)和性功能障碍(SxD)分别降低生活质量(QOL),但在未选择人群中它们重叠的影响尚未研究。

目的

评估 IBS 女性伴或不伴 SxD 的 QOL,并与对照组进行比较。

方法

在这项横断面评估中,我们研究了 51 名 IBS 女性(罗马 IV 标准)和 54 名对照组。使用女性性功能指数问卷确定 SxD。使用简明 36 项健康调查量表(SF-36)和 IBS-QOL 问卷评估 QOL。

结果

IBS 女性(39.22%)与对照组(38.89%)的 SxD 患病率相似。与其他组相比,IBS 伴 SxD 患者在所有领域以及 SF-36 的身体和心理综合评分以及 IBS-QOL 的几乎所有领域(除了身体形象、食物回避和社会反应与 IBS 患者无 SxD 相比)和总分方面的评分较低。

结论

这些发现表明 SxD 会降低 IBS 女性的一般和特定 QOL。在 IBS 患者中考虑 SxD 将使我们能够采取更有效的诊断和治疗方法。墨西哥城总医院临床试验注册处:DI/19/107/03/080。

临床试验注册号

NCT04716738。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8fb0/10045848/a3d65f7bf29c/12905_2023_2272_Fig1_HTML.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索